How People Voted
100% For, 0% Against
1 vote cast
S. 2236, The Advancing Breakthrough Therapies for Patients Act of 2012
- This item is from the 112th Congress (2011-2012) and is no longer current. Comments, voting, and wiki editing have been disabled, and the cost/savings estimate has been frozen.
S. 2236 would provide for the expedited development and evaluation of drugs designated as breakthrough drugs.